FDA inspection
APEX Biologix, LLC: FDA inspection ending Sep 1, 2022
FDA inspection 1178720 · Voluntary Action Indicated (VAI) · Woods Cross, UT
Key facts
| Inspection ID | 1178720 |
|---|---|
| Firm | APEX Biologix, LLC |
| FEI number | 3013756523 |
| Address | 2561 S 1560 W Ste B |
| City | Woods Cross |
| State | UT |
| ZIP | 84087 |
| Country | United States |
| Fiscal year | 2022 |
| Inspection end date | Sep 1, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data